Gx2 (T)

Tirzepatide (Dual GLP-1 / GIP Agonist Peptide)
Tirzepatide is a cutting-edge peptide that activates both GLP-1 and GIP receptors to support metabolic regulation, glucose control, and healthy weight management. Engineered for extended duration, it offers once-weekly convenience and pronounced benefits.

Potential Benefits:
• Substantial reduction in HbA1c and improved glycemic control
• Significant weight loss, including reductions in visceral fat
• Favorable improvements in lipid levels and metabolic markers
• Cardiometabolic support, including lower cardiovascular risk markers
• Convenient weekly-dosing profile

Usage & Safety Notes:
• For research use only; not approved or endorsed by all regulatory agencies for medical or therapeutic use.

Each batch has been independently 3rd party tested – COAs will be placed on the website soon! You are welcome to reach out via support@moxiepureresearch.co if you need a copy of COA for your research.